CLRI News Clearant to Present at Noble Financial Small Cap Conference
LOS ANGELES--(BUSINESS WIRE)--Sept. 18, 2006--Clearant, Inc. (OTCBB:CLRI) today announced that the Company will present at the Noble Financial Small Cap Conference to be held at the Ballantyne Resort in Charlotte, North Carolina September 26-28, 2006.
Jon Garfield, chief financial officer of Clearant, will present on Tuesday, September 26, 2006 at 12:45 p.m. Eastern time, and will provide an update on the Company's new direct sales growth initiative, which started in June 2006 and is designed to sell its Clearant Process sterile implants directly to hospitals and end user surgeons.
Interested parties can access an audio webcast of the presentation from a dedicated website provided by Noble Financial at www.ontrack06.com.
About Clearant, Inc.
Clearant, Inc. is a leader in pathogen inactivation for biological products. Clearant has developed the patent-protected Clearant Process, which substantially reduces all types of bacteria and viruses in biological products while maintaining the functionality of the underlying tissue implant or protein. The Company began to distribute directly to surgeons, hospitals and clinics Clearant Process sterile implants in June 2006; in addition, Clearant continues to license the Clearant Process and provides its patented sterilization services to tissue banks and other biological products manufacturers. As of the end of 1Q 2006, Clearant had 10 license and service agreements with tissue banks. To date more than 8,000 patients have been successfully implanted with Clearant Process sterile implants supplied by one of the Company's licensed partners. Whereas various competing sterilization methods only kill specific types of pathogens (such as bacteria or lipid-enveloped viruses) for specific products, the Clearant Process reduces all types of pathogens for products across many market segments including tissue implants, plasma proteins, recombinant products, medical devices and blood products. Also, the Clearant Process can be applied at various stages of product processing and/or manufacturing, including in the final packaging. For more information, please visit www.clearant.com.
